Mr. Kroll has seventeen years of experience in the medical device industry. He has senior management experience, has conducted animal and pre-clinical human studies, and developed new surgical procedures for implanting medical devices. His experience includes both class II and III medical devices in the U.S., implantable and external. He was most recently VP of R&D at OncoStim, Inc. Prior to that, he was Director of Research at St. Croix Medical, now Envoy Medical. Mr. Kroll holds 48 issued U.S. patents and a B.S. & M.S. from the University of Minnesota. Mr. Kroll serves as Chairman of Galvani, Ltd.
Mr. Adinolfi is currently on the board of the Ridgeview Foundation and CreateHealth, Inc. He served as the President, St. Jude Medical Daig Division until Feb. 1, 2005. He was with St. Jude Medical for 15 years with extensive senior executive responsibilities in General Management, Marketing, Product Development, Business Development and Strategic Planning. Mr. Adinolfi has 6 issued US patents. Prior to joining St. Jude, Mr. Adinolfi worked 5 years at Siemens and 5 years at Cordis Corporation, a Johnson & Johnson company.
Dr. Kroll is currently the Chairman of Newcardio, Incorporated. Dr. Kroll formerly served as the Senior Vice President and Chief Technology Officer for the Cardiac Rhythm Management division of St. Jude Medical Inc. Dr. Kroll is the named inventor on over 280 U.S. patents as well as numerous international patents. He serves as an Adjunct Professor of Biomedical Engineering at both California Polytechnic University-San Luis Obispo, California, and at the University of Minnesota. Dr. Kroll is also a director of Haemonetics Corporation and Taser International, Inc.
Dr. Smith was most recently the Chairman of Taser International, Inc. He is the Former Director and CEO of Pentawave, Inc. He is also the former President and CEO of Zycad Corporation and CAE Systems, Inc. as well as the former Chairman and CEO of Edge Computer. Dr. Smith received his B.S. from West Point, his M.B.A from Michigan State and his Ph.D. from St. Louis University.
Dr. Schroeppel was formerly the President of Ionix Medical. Dr. Schroeppel has 33 years of experience in the medical device industry and has held the top technical position in two major implantable device corporations: Cordis Corporation and Intermedics, Inc. He holds 54 issued U.S. patents.
Mr. Wylie is currently Vice President of Finance at Four51. Mr. Wylie’s broad experience has guided technology companies during various growth stages, from start-up through IPO and beyond. Mr. Wylie has served as CFO for NEO Networks, Inc. and Rimage Corp.